The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols
Abstract
The treatment of cancer with chemotherapeutic agents and radiation has two major problems: time-dependent development of tumor resistance to therapy (chemoresistance and radioresistance) and nonspecific toxicity toward normal cells. Many plant-derived polyphenols have been studied intently for their potential chemopreventive properties and are pharmacologically safe. These compounds include genistein, curcumin, resveratrol, silymarin, caffeic acid phenethyl ester, flavopiridol, emodin, green tea polyphenols, piperine, oleandrin, ursolic acid, and betulinic acid. Recent research has suggested that these plant polyphenols might be used to sensitize tumor cells to chemotherapeutic agents and radiation therapy by inhibiting pathways that lead to treatment resistance. These agents have also been found to be protective from therapy-associated toxicities. How these polyphenols protect normal cells and sensitize tumor cells to treatment is discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 3,017
Self-citationCancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Mechanisms of Caspase Activation and Inhibition during Apoptosis
Shi, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00482-3 · Cited by 1,833
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,656
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Natarajan, K., Singh, S., Burke, T. R., Grunberger, D., & Aggarwal, B. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9090 · Cited by 1,139
Self-citationAberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6509 · Cited by 879
Self-citationLevy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Huang, S., Bock, J. M., & Harari, P. M. (1999) · PubMed · Cited by 714
Bharti, A. C., Donato, N., Singh, S., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-05-1320 · Cited by 685
Self-citationThe Current Status of Camptothecin Analogues as Antitumor Agents
Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., & Kaufmann, S. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.271 · Cited by 618
Huang, S., & Harari, P. M. (2000) · PubMed · Cited by 555
Charles F. Kettring prize. Fundamental studies with cisplatin
Rosenberg, B. (1985) · Cancer · doi:10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l · Cited by 517
Nuclear factor-kappa B and cancer: its role in prevention and therapy
Bharti, A. C., & Aggarwal, B. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01154-1 · Cited by 510
Self-citationIn vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas, L., Mason, K. A., Hunter, N. R., et al. (2000) · PubMed · Cited by 503
Arlt, A., Gehrz, A., Müerköster, S., Vorndamm, J., Kruse, M.-L., Fölsch, U. R., & Schäfer, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206390 · Cited by 474
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells
Knuefermann, C., Lu, Y., Liu, B., Jin, W., Liang, K., Wu, L., Schmidt, M., Mills, G. B., Mendelsohn, J., & Fan, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206394 · Cited by 452
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4
Bhardwaj, R. K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S. K., & Fromm, M. F. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034728 · Cited by 444
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 441
Self-citationNuclear transcription factor-κB as a target for cancer drug development
Garg, A., & Aggarwal, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402482 · Cited by 441
Self-citationA role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
Shishodia, S., Majumdar, S., Banerjee, S., & Aggarwal, B. B. (2003) · PubMed · Cited by 426
Self-citationMichaluart, P., Masferrer, J. L., Carothers, A. M., Subbaramaiah, K., Zweifel, B. S., Koboldt, C. M., MESTRE, J. R., Grünberger, D., Sacks, P. G., Tanabe, T., et al. (1999) · PubMed · Cited by 410
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
Jang, J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 390
Akimoto, T., Hunter, N. R., Buchmiller, L., Mason, K. A., Ang, K. K., & Milas, L. (1999) · PubMed · Cited by 357
Roles of STAT3 defined by tissue-specific gene targeting
Akira, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203478 · Cited by 344
Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.
Mendelsohn, J. M. (1997) · PubMed · Cited by 344
Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells
O'Connor, D. S., Schechner, J. S., Adida, C., Mesri, M., Rothermel, A. L., Li, F., Nath, A. K., Pober, J. S., & Altieri, D. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64742-6 · Cited by 341
Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y., & Orlowski, R. Z. (2002) · PubMed · Cited by 336
Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K., Agarwal, M. L., & Mukhtar, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206708 · Cited by 325
Tyagi, A. K., Singh, R. P., Agarwal, C., Chan, D. C. F., & Agarwal, R. (2002) · PubMed · Cited by 323
Real, P. J., Sierra, A., de Juan, A., Segovia, J. C., Lopez-Vega, J. M., & Fernandez-Luna, J. L. (2002) · Oncogene · doi:10.1038/sj.onc.1206004 · Cited by 321
Bharti, A. C., Shishodia, S., Reuben, J. M., Weber, D., Alexanian, R., Raj-Vadhan, S., Estrov, Z., Talpaz, M., & Aggarwal, B. B. (2004) · Blood · doi:10.1182/blood-2003-06-2151 · Cited by 318
Self-citationEnhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
Mechanisms of Cancer Chemoprevention by Soy Isoflavone Genistein
Sarkar, F. H., & Li, Y. (2002) · Cancer and Metastasis Reviews · doi:10.1023/a:1021210910821 · Cited by 317
Aziz, M., Kumar, R., & Ahmad, N. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.1.17 · Cited by 316
A p34cdc2 survival checkpoint in cancer
O'Connor, D. S., Wall, N. R., Porter, A. C. G., & Altieri, D. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00084-3 · Cited by 315
Zhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3
Chendil, D., Ranga, R. S., Meigooni, D., Sathishkumar, S., & Ahmed, M. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207284 · Cited by 308
Li, Y., & Sarkar, F. H. (2002) · PubMed · Cited by 298
Anuchapreeda, S., Leechanachai, P., Smith, M. M., Ambudkar, S. V., & Limtrakul, P.-N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01224-8 · Cited by 291
Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.
Altieri, D. C., Marchisio, P. C., & Marchisio, C. (1999) · PubMed · Cited by 289
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells.
Mori, N., Fujii, M., Ikeda, S., Yamada, Y., Tomonaga, M., Ballard, D. W., & Yamamoto, N. (1999) · PubMed · doi:10.1182/blood.v93.7.2360 · Cited by 285
Activation of STAT proteins and growth control
Bromberg, J. F. (2001) · BioEssays · doi:10.1002/1521-1878(200102)23:2<161::aid-bies1023>3.0.co;2-0 · Cited by 279
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Kishi, K., Petersen, S. H., Petersen, C., Hunter, N. R., Mason, K. A., Masferrer, J. L., Tofilon, P. J., & Milas, L. (2000) · PubMed · Cited by 275
Bharti, A. C., Takada, Y., & Aggarwal, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5940 · Cited by 268
Self-citationUkil, A., Maity, S., Karmakar, S., Datta, N., Vedasiromoni, J. R., & Das, P. K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705241 · Cited by 268
Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J., & Sonenshein, G. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204257 · Cited by 265
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
Kaufmann, S. H., & Vaux, D. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206945 · Cited by 265
Bible, K. C., & Kaufmann, S. H. (1997) · PubMed · Cited by 258
Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
Wall, N. R., O’Connor, D. S., Plescia, J., Pommier, Y. G., & Altieri, D. C. (2003) · PubMed · Cited by 252
Genistein Inhibits NF-kB Activation in Prostate Cancer Cells
Davis, J. N., Kucuk, O., & Sarkar, F. H. (1999) · Nutrition and Cancer · doi:10.1207/s15327914nc352_11 · Cited by 250
Philip, S., Bulbule, A., & Kundu, G. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103334200 · Cited by 247
Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors
Pisters, K. M. W., Newman, R. A., Coldman, B., Shin, D. M., Khuri, F. R., Hong, W. K., Glisson, B. S., & Lee, J. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1830 · Cited by 243
Di Pietro, A., Conseil, G., Pérez-Victoria, J. M., Dayan, G., Baubichon-Cortay, H., Trompier, D., Steinfels, E., Jault, J.-M., de Wet, H., Maitrejean, M., et al. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8424-8 · Cited by 241
Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells
Gong, L., Li, Y., Nedeljkovic-Kurepa, A., & Sarkar, F. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206583 · Cited by 237
Curcumin attenuation of acute adriamycin myocardial toxicity in rats
Venkatesan, N. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701877 · Cited by 235
Masuda, M., Suzui, M., Lim, J. T. E., Deguchi, A., Soh, J., & Weinstein, I. B. (2002) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2002.01062.x · Cited by 235
Curcumin prevents adriamycin nephrotoxicity in rats
Venkatesan, N., Punithavathi, D., & Arumugam, V. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703067 · Cited by 231
Reactive oxygen intermediates in TNF signaling
Garg, A. K., & Aggarwal, B. B. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00207-9 · Cited by 228
Self-citationMolecular mechanism of the chemopreventive effect of resveratrol
Dong, Z. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00330-5 · Cited by 227
Chen, Y.-C., Shen, S.-C., Lee, W.-R., Hsu, F.-L., Lin, H.-Y., Ko, C.-H., & Tseng, S.-W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01386-2 · Cited by 226
Interaction of the breast cancer resistance protein with plant polyphenols
Cooray, H. C., Janvilisri, T., van Veen, H. W., Hladky, S. B., & Barrand, M. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.040 · Cited by 226
Enhancement of Tumor Response to -Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme
Milas, L., Kishi, K., Hunter, N. R., Mason, K. A., Masferrer, J. L., & Tofilon, P. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1501 · Cited by 225
Gupta, S., Hastak, K., Afaq, F., Ahmad, N., & Mukhtar, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207353 · Cited by 218
Khajuria, A., Thusu, N., & Zutshi, U. (2002) · Phytomedicine · doi:10.1078/0944-7113-00114 · Cited by 217
Takada, Y., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3278 · Cited by 212
Self-citationZwelling, L. A., Michaels, S., Schwartz, H., Dobson, P. P., & Kohn, K. W. (1981) · PubMed · Cited by 210
Pianetti, S., Guo, S., Kavanagh, K. T., & Sonenshein, G. E. (2002) · PubMed · Cited by 207
Petersen, C., Petersen, S. H., Milas, L., Lang, F. F., & Tofilon, P. J. (2000) · PubMed · Cited by 206
Reactive oxygen species are downstream products of TRAF-mediated signal transduction
Chandel, N. S., Schumacker, P. T., & Arch, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103074200 · Cited by 203
Park, O. J., & Surh, Y.-J. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.06.001 · Cited by 203
Inhibitory Effect of Caffeic Acid Phenethyl Ester on Angiogenesis, Tumor Invasion, and Metastasis
Liao, H.-F., Chen, Y.-Y., Liu, J.-J., Hsu, M.-L., Shieh, H.-J., Liao, H.-J., Shieh, C.-J., Shiao, M.-S., & Chen, Y.-J. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034729d · Cited by 202
Pyo, H., Choy, H., Amorino, G. P., Js, K., Cao, Q., Hercules, S. K., & DuBois, R. N. (2001) · PubMed · Cited by 201
Chen, C.-C., Sun, Y.-T., Chen, J.-J., & Chiu, K.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2719 · Cited by 197
Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
Maccarrone, M., Lorenzon, T., Guerrieri, P., & Agrò, A. F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00630.x · Cited by 195
Linard, C., Marquette, C., Mathieu, J., Pennequin, A., Clarençon, D., & Mathé, D. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.039 · Cited by 188
Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., & Castronovo, V. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90448-0 · Cited by 185
Mesri, M., Morales-Ruiz, M., Ackermann, E. J., Bennett, C. F., Pober, J. S., Sessa, W. C., & Altieri, D. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64131-4 · Cited by 183
Atal, C. K., Dubey, R. K., & Singh, J. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20081-7 · Cited by 180
Takada, Y., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304546200 · Cited by 169
Self-citationHong, J., Lambert, J. D., Lee, S.-H., Sinko, P. J., & Yang, C. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.007 · Cited by 169
Epidemiology of digestive tract cancers in India. V. Large and small bowel.
Mohandas, K. M., & Desai, D. C. (1999) · PubMed · Cited by 166
Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis
Greten, F. R., Weber, C. K., Greten, T. F., Schneider, G., Wagner, M., Adler, G., & Schmid, R. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.37075 · Cited by 166
Jazirehi, A. R., & Bonavida, B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.71.3.1 · Cited by 163
Zhang, L., Chang, C., Bacus, S. S., & Hung, M. (1995) · PubMed · Cited by 162
Cusack, J. C., Liu, R., & Baldwin, A. S. (2000) · PubMed · Cited by 160
Chuang, S.-E., Yeh, P.-Y., Lu, Y.-S., Lai, G.-M., Liao, C.-M., Gao, M., & Cheng, A.-L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00931-0 · Cited by 159
Jagetia, G. C., Baliga, M. S., Venkatesh, P., & Ulloor, J. N. (2003) · Radiation Research · doi:10.1667/rr3057 · Cited by 159
Bano, G., Raina, R. K., Zutshi, U., Bedi, K. L., Johri, R. K., & Sharma, S. C. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314996 · Cited by 157
Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Cal, C., Garbán, H., Jazirehi, A. R., Yeh, C.-H., Mizutani, Y., & Bonavida, B. (2003) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011033353443 · Cited by 152
Zhang, L., Lau, Y. K. J., Xia, W., Hortobágyi, G. N., & Hung, M. (1999) · PubMed · Cited by 150
Yi, J., Yang, J., He, R. L., Gao, F., Sang, H., Tang, X., & Ye, R. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2820-2 · Cited by 149
Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
Limtrakul, P., Anuchapreeda, S., & Buddhasukh, D. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-13 · Cited by 148
Nomura, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.10.1885 · Cited by 148
Survivin As a Therapeutic Target for Radiation Sensitization in Lung Cancer
Lü, B., Mu, Y. M., Cao, C., Zeng, F., Schneider‐Burrus, S., Tan, J., Price, J., Chen, J., Freeman, M. L., & Hallahan, D. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3547 · Cited by 145
Activation of Cancer-Specific Gene Expression by the Survivin Promoter
Bao, R., Connolly, D. C., Murphy, M., Green, J., Weinstein, J. K., Pisarcik, D. A., & Hamilton, T. C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.522 · Cited by 135
Hour, T., Chen, J., Huang, C., Guan, J., Lu, S., & Pu, Y. (2002) · The Prostate · doi:10.1002/pros.10089 · Cited by 130
Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale)
Sharma, S., & Gupta, Y. K. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00053-1 · Cited by 126
Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy
Koki, A. T., Leahy, K. M., & Masferrer, J. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1623 · Cited by 124
Li, Y., Ellis, K.-L., Ali, S. S., El-Rayes, B. F., Nedeljkovic-Kurepa, A., Kucuk, O., Philip, P. A., & Sarkar, F. H. (2004) · Pancreas · doi:10.1097/00006676-200405000-00020 · Cited by 119
Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs
Sharma, S., Kochupillai, V., Gupta, S., Seth, S. D. S., & Gupta, Y. K. (1997) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00054-8 · Cited by 119
Motwani, M., Jung, C. P., Sirotnak, F. M., She, Y., Shah, M. A., Gönen, M., & Schwartz, G. K. (2001) · PubMed · Cited by 116
ABC transporters and inhibitors: new targets, new agents.
Leonard, G. D., Polgár, O., & Bates, S. E. (2002) · PubMed · Cited by 115
Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats
Özyurt, H., Söğüt, S., Yıldırım, Z., Kart, L., Iraz, M., Armutçu, F., Temel, İ., Özen, S., Uzun, A., & Akyol, Ö. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.09.015 · Cited by 115
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
Jin, W., Wu, L., Liang, K., Liu, B., Lü, Y., & Fan, Z. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601048 · Cited by 115
Tanno, S., Yanagawa, N., Habiro, A., Koizumi, K., Nakano, Y., Osanai, M., Mizukami, Y., Okumura, T., Testa, J. R., & Kohgo, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1788 · Cited by 113
Zhang, L., & Hung, M. (1996) · PubMed · Cited by 113
Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology
Belka, C., & Budach, W. (2002) · International Journal of Radiation Biology · doi:10.1080/09553000210137680 · Cited by 111
Chemoradiotherapy: Emerging treatment improvement strategies
Milas, L., Mason, K. A., Liao, Z. X., & Ang, K. K. (2002) · Head & Neck · doi:10.1002/hed.10232 · Cited by 111
4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1982) · PubMed · Cited by 110
Zoberi, I., Bradbury, C. M., Curry, H. A., Bisht, K. S., Goswami, P. C., Roti, J. L. R., & Gius, D. R. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00719-4 · Cited by 110
Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity.
Thresiamma, K. C., George, J., & Kuttan, R. (1998) · PubMed · Cited by 109
Zhu, L., Fukuda, S., Cordis, G. A., Das, D. K., & Maulik, N. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03084-8 · Cited by 108
Jung, C. P., Motwani, M., & Schwartz, G. K. (2001) · PubMed · Cited by 106
Tainton, K. M., Smyth, M. J., Jackson, J. T., Tanner, J. E., Cerruti, L., Jane, S. M., Darcy, P. K., & Johnstone, R. W. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401440 · Cited by 106
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer
Hengstler, J. G., Lange, J., Kett, A., Dornhöfer, N., Meinert, R., Arand, M., Knapstein, P. G., Becker, R., Oesch, F., & Tanner, B. (1999) · PubMed · doi:10.5167/uzh-113865 · Cited by 106
Scambia, G., Vincenzo, R. D., Ranelletti, P. O., Panici, P. B., Ferrandina, G., D’Agostino, G. R., Fattorossi, A., Bombardelli, E., & Mancuso, S. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00011-1 · Cited by 103
Khajuria, A., Zutshi, U., & Bedi, K. L. (1998) · PubMed · Cited by 103
Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
Chen, X., Shen, B., Xia, L., Khaletzkiy, A., Chu, D. T. W., Wong, J. Y. C., & Li, J. J. (2002) · PubMed · Cited by 102
Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan
Suzuki, Y., Tsubono, Y., Nakaya, N., Suzuki, Y., Koizumi, Y., & Tsuji, I. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601652 · Cited by 101
Sadzuka, Y., Sugiyama, T., & Sonobe, T. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00290-8 · Cited by 99
Nicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A. E., & Tredici, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01654-8 · Cited by 99
Vayalil, P. K., & Katiyar, S. K. (2003) · The Prostate · doi:10.1002/pros.10352 · Cited by 99
Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization
Bharti, A. C., & Aggarwal, B. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04671.x · Cited by 98
Self-citationRadiosensitization of Human Melanoma Cells by Ribozyme-Mediated Inhibition of Survivin Expression
Pennati, M., Binda, M., Colella, G., Folini, M., Villa, R., Daidone, M. G., Zaffaroni, N., & Citti, L. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12082.x · Cited by 97
Phosphatidylinositide 3-kinase/AKT in radiation responses.
Zhan, M., & Han, Z. (2004) · PubMed · doi:10.14670/hh-19.915 · Cited by 96
Weaver, K. D., Yeyeodu, S. T., Cusack, J. C., Baldwin, A. S., & Ewend, M. G. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022554824129 · Cited by 95
N. YAMAGISHI, J. M. A. H. T. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143374 · Cited by 95
Nakata, E., Mason, K. A., Hunter, N. R., Husain, A., Raju, U., Liao, Z. X., Ang, K. K., & Milas, L. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.061 · Cited by 94
Natarajan, K., Manna, S. K., Chaturvedi, M. M., & Aggarwal, B. B. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0576 · Cited by 92
Self-citationKim, D., Koo, S., Jeon, K., et al. (2003) · PubMed · Cited by 90
A Role for Survivin in Radioresistance of Pancreatic Cancer Cells
Asanuma, K., Kobayashi, D., Furuya, D., Tsuji, N., Yagihashi, A., & Watanabe, N. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02483.x · Cited by 89
Akimoto, T., Nonaka, T., Ishikawa, H., Sakurai, H., Saitoh, J., Takahashi, T., & Mitsuhashi, N. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01560-1 · Cited by 89
Protection of radiation-induced protein damage by curcumin
Kapoor, S., & Priyadarsini, K. I. (2001) · Biophysical Chemistry · doi:10.1016/s0301-4622(01)00188-0 · Cited by 89
Genistein potentiates the radiation effect on prostate carcinoma cells.
Hillman, G. G., Forman, J. D., Kucuk, O., Yudelev, M., Maughan, R. L., Rubio, J., Layer, A., Tekyi‐Mensah, S., Abrams, J., & Sarkar, F. H. (2001) · PubMed · Cited by 88
NF-κB signaling pathway as a target for human tumor radiosensitization
Jung, M., & Dritschilo, A. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.26034 · Cited by 86
NF- κ B and chemoresistance: potentiation of cancer drugs via inhibition of NF- κ B
Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0094 · Cited by 86
Ahmad, K. A., Clement, M., Hanif, I. M., & Pervaiz, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2414 · Cited by 86
Modulation of cancer chemotherapy by green tea.
Sadzuka, Y., Sugiyama, T., & Hirota, S. (1998) · PubMed · Cited by 80
Chlopčíková, Š., Psotová, J., Miketová, P., & Šimánek, V. (2004) · Phytotherapy Research · doi:10.1002/ptr.1415 · Cited by 78
Inano, H., & Onoda, M. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02794-3 · Cited by 77
Sugiyama, T., & Sadzuka, Y. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00031-3 · Cited by 75
Raju, U., Nakata, E., Mason, K. A., Ang, K. K., & Milas, L. (2003) · PubMed · Cited by 74
Büchler, P., Gukovskaya, A. S., Mouria, M., Büchler, M. C., Büchler, M. W., Frieß, H., Pandol, S. J., Reber, H. A., & Hines, O. J. (2003) · Pancreas · doi:10.1097/00006676-200304000-00010 · Cited by 69
Terakado, N., Shintani, S., Yano, J., Li, C., Mihara, M., Nakashiro, K., & Hamakawa, H. (2003) · Oral Oncology · doi:10.1016/j.oraloncology.2003.09.005 · Cited by 69
The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin
Sadzuka, Y., Sugiyama, T., Miyagishima, A., Nozawa, Y., & Hirota, S. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04282-6 · Cited by 68 · cited 1×
“Another study showed that, compared with doxorubicin alone, theanine plus doxorubicin enhanced the antitumor effect over twofold in mice with Ehrlich ascites carcinoma (158).”
BackgroundMultidrug Resistance in Prostate Cancer
van Brussel, J. P., & Mickisch, G. (2003) · Oncology Research and Treatment · doi:10.1159/000071510 · Cited by 68
Targeting tumor cells by enhancing radiation sensitivity
McKenna, W. G., & Muschel, R. J. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10296 · Cited by 67
Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma.
SUGIYAMA, T., & Sadzuka, Y. (1999) · PubMed · Cited by 67
Newton, T. R., Patel, N. M., Bhat‐Nakshatri, P., Stauss, C. R., Goulet, R. J., & Nakshatri, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18827 · Cited by 64
Lei, W., Mayotte, J., & Levitt, M. L. (1999) · PubMed · Cited by 64
Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells
Hövelmann, S., Beckers, T. L., & Schmidt, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601876 · Cited by 63
Sugiyama, T., & Sadzuka, Y. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00185-2 · Cited by 63
Milas, L., & Hanson, W. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00327-f · Cited by 58
Okabe, S., Fujimoto, N., Sueoka, N., Suganuma, M., & Fujiki, H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.883 · Cited by 56
Annabi, B., & Lee, Y. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.529 · Cited by 54
Inhibition of cytotoxic drug-induced vomiting in suncus by a ginger constituent
Yamahara, J., Huang, R., Naitoh, Y., Kitani, T., & Fujimura, H. (1989) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(89)90010-x · Cited by 54
Papazisis, K. T., Zambouli, D., Kimoundri, O., Papadakis, E. S., Vala, V., Geromichalos, G. D., Voyatzi, S., Markala, D., Destouni, E., Boutis, L., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00569-3 · Cited by 53
Molecular and pharmacological strategies to overcome multidrug resistance
Shabbits, J. A., Krishna, R., & Mayer, L. D. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.4.585 · Cited by 51
Protease inhibitors restore radiation‐induced apoptosis to Bcl‐2‐expressing lymphoma cells
Kurland, J. F., & Meyn, R. E. (2001) · International Journal of Cancer · doi:10.1002/ijc.1040 · Cited by 46
Khoshyomn, S., Manske, G. C., Lew, S. M., Wald, S. L., & Penar, P. L. (2000) · Pediatric Neurosurgery · doi:10.1159/000028993 · Cited by 43
Shigeoka, Y., Igishi, T., Matsumoto, S., Nakanishi, H., Kodani, M., Yasuda, K., Hitsuda, Y., & Shimizu, E. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0520-0 · Cited by 42
Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin
Sugiyama, T., Sadzuka, Y., Nagasawa, K., Ohnishi, N., Yokoyama, T., & Sonobe, T. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00814.x · Cited by 40
Allameh, A., Saxena, M., Biswas, G., Raj, H. G., Singh, J., & Srivastava, N. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90287-6 · Cited by 40
Rath, P. C., & Aggarwal, B. B. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900152434402 · Cited by 39
Self-citationPark, J., Oh, E., Choi, Y., Kang, C.-D., Kang, H. S., Kim, D.-K., Kang, K., & Yoo, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.5.997 · Cited by 39
Genistein reduces NF-κB in T lymphoma cells via a caspase-mediated cleavage of IκBα
Baxa, D. M., & Yoshimura, F. K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00415-5 · Cited by 38
Flynn, V. J., Ramanitharan, A., Moparty, K., Davis, R., Sikka, S. C., Agrawal, K. C., & Abdel‐Mageed, A. B. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.2.317 · Cited by 38
Li, W., Fan, J., & Bertino, J. R. (2001) · PubMed · Cited by 37
Sadzuka, Y. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00491-2 · Cited by 34
Tacchini, L., Dansi, P., Matteucci, E., & Desiderio, M. A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4824 · Cited by 32
Nuclear factor-κB as a predictor of treatment response in breast cancer
Garg, A. K., Hortobágyi, G. N., Aggarwal, B. B., Şahin, A. A., & Buchholz, T. A. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00001 · Cited by 30
Self-citationDeregowski, V., Delhalle, S., Benoît, V., Bours, V., & Merville, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01151-6 · Cited by 30
Wietrzyk, J., Boratyński, J., Grynkiewicz, G., Ryczynski, A., Radzikowski, C., & Opolski, A. (2002) · PubMed · Cited by 28
Calvin, D. P., Nam, S., Buettner, R., Sekharam, M., Torres-Roca, J. F., & Jove, R. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01158-1 · Cited by 20
Tamura, S., Bito, T., Ichihashi, M., & Ueda, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00068.x · Cited by 18
Komatsu, K., Tauchi, H., Yano, N., Endo, S., Matsuura, S., & Shoji, S. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04555-7 · Cited by 15
Cited by
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Self-citationGlycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding
Perron, N. R., & Brumaghim, J. L. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9043-x · Cited by 1,370
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Self-citation
Metadata
- Authors
- Garg, A. K., Buchholz, T. A., & Aggarwal, B. B.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2005-11
- Volume
- 7
- Issue
- 11-12
- Pages
- 1630-1647
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1972685575
- Cited by
- 278
- References
- 193
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.